SUPPLEMENT SCIENCEInsights
Search

Search Insights

Try choline, nano-curcumin or probiotics.

    Botanical guide · Ingredient reference

    Curcumin in rheumatoid arthritis: an early pilot cannot replace disease-control evidence

    A 45-person pilot reported favorable rheumatoid arthritis symptom scores with curcumin. Its small active-comparator design does not establish prevention of joint damage or a replacement for prescribed treatment.

    Read the evidence ↓

    Supplement Science Insights Editorial Team

    Published September 23, 2026

    The study compared three active approaches

    People with active rheumatoid arthritis were randomized to curcumin, diclofenac or their combination. Disease-activity scores improved in all three groups, with the curcumin group showing the largest reported percentage improvements. [1]

    The trial was described as a pilot and did not include a placebo group. Its authors called for larger studies to validate the findings. [1]

    Short-term scores are not the whole treatment goal

    The abstract does not establish long-term structural joint outcomes or equivalence to disease-modifying rheumatoid arthritis treatment. It also does not fully specify blinding, intervention duration, funding or conflicts. [1]

    No curcumin-related adverse events were reported, but a small trial has limited power to detect uncommon harms. These findings can motivate research; they do not justify stopping rheumatology treatment or assuming that all turmeric preparations have the same effect as the studied curcumin product. [1]

    Ask whether the outcome matches the treatment claim

    Imagine joint tenderness improves during a short study. That alone does not show that long-term joint damage is prevented or that a prescribed disease-modifying medicine is unnecessary.

    Evidence summary — Curcumin in rheumatoid arthritis
    DetailInterpretation
    45 participantsPilot scale
    DAS28 and ACR measuresReported symptom/activity findings
    Joint-damage preventionNot established
    Curcumin in rheumatoid arthritis: an early pilot cannot replace disease-control evidence — original article outline diagram
    Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

    Sources for this article

    1. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis - PubMed
      Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.